======= GLYR1 ======= == Gene Information == * **Official Symbol**: GLYR1 * **Official Name**: glyoxylate reductase 1 homolog * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=84656|84656]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q49A26|Q49A26]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GLYR1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GLYR1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610660|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |NAD binding 2| |F420 oxidored| |PWWP| |NADP binding| |NAD binding| |methylated histone binding| |nucleosome| |oxidoreductase activity| |histone binding| |nuclear speck| |oxidation-reduction process| |Golgi apparatus| |DNA binding| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp59|UMK57 1μM R01 exp59]]|-2.39| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|-2.08| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|-1.85| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|-1.79| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|-1.75| |[[:results:exp222|Betulinic acid 10 to 15μM on day4 R05 exp222]]|1.71| |[[:results:exp417|Tubastatin-A 2.5μM R07 exp417]]|1.71| |[[:results:exp70|INK128 0.2μM R02 exp70]]|1.72| |[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|1.82| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|1.85| |[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|1.88| |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|1.99| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|2.13| |[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|2.15| |[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|2.26| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|2.28| |[[:results:exp306|Rapamycin 2μM R07 exp306]]|2.33| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|2.62| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|2.71| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|3.11| ^Gene^Correlation^ |[[:human genes:p:pcgf1|PCGF1]]|0.505| |[[:human genes:i:ikzf2|IKZF2]]|0.484| |[[:human genes:k:kdm6a|KDM6A]]|0.473| |[[:human genes:c:cdk8|CDK8]]|0.464| |[[:human genes:r:ring1|RING1]]|0.454| |[[:human genes:p:ptma|PTMA]]|0.433| |[[:human genes:u:ube2e1|UBE2E1]]|0.416| |[[:human genes:g:gsk3b|GSK3B]]|0.415| |[[:human genes:c:creb1|CREB1]]|0.413| |[[:human genes:y:ypel5|YPEL5]]|0.412| |[[:human genes:a:anp32a|ANP32A]]|0.409| |[[:human genes:b:bcor|BCOR]]|0.408| |[[:human genes:g:gskip|GSKIP]]|0.408| |[[:human genes:p:pou2af1|POU2AF1]]|0.405| Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 14117 * **Expression level (log2 read counts)**: 7.18 {{:chemogenomics:nalm6 dist.png?nolink |}}